Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trialFrederick J. Raal, Stanley T. Crooke, Raúl D. Santos et al.|The Lancet|2010Cited by 905
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatmentAlbert Wiegman, Olov Wiklund, Jan Albert Kuivenhoven et al.|European Heart Journal|2015Cited by 868
The Agenda for Familial HypercholesterolemiaSamuel S. Gidding, Anthony S. Wierzbicki, Mary Ann Champagne et al.|Circulation|2015Cited by 726
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and managementRobert A. Hegele, Olov Wiklund, Henry N. Ginsberg et al.|The Lancet Diabetes & Endocrinology|2013Cited by 632
Homozigot ailevi hiperkolesterolemi: klinisyenlerin tanıyı ve klinik yönetimi geliştirmelerine yönelik yeni anlayışlar ve rehberlik. Avrupa Ateroskleroz Derneği’nin Ailevi Hiperkolesterolemi Üzerine Uzlaşı Paneli yazılı görüşüMarina Cuchel, M. John Chapman, Éric Bruckert et al.|Unknown|2015Cited by 465